Current technologies in the complex treatment of intrahepatic cholestasis of pregnancy


Citar

Texto integral

Resumo

A prospective study was made in 63 pregnant women with intrahepatic cholestasis. Twenty-seven pregnant women underwent discrete plasmapheresis during complex therapy for intrahepatic cholestasis (Group 1) and 36 women had complex therapy only. Analysis of the findings has demonstrated that inclusion of plasmapheresis into the complex therapy of intrahepatic cholestasis improves clinical and laboratory parameters, promotes prolongation of pregnancy and a reduction in perinatal complications.

Sobre autores

A Nikolayeva

Academician V. I. Kulakov Research Center of Obstetrics, Gynecology, and Perinatology, Russian Agency for Medical Technologies, Moscow

Email: irgly@rambler.ru
Academician V. I. Kulakov Research Center of Obstetrics, Gynecology, and Perinatology, Russian Agency for Medical Technologies, Moscow

T Fedorova

Academician V. I. Kulakov Research Center of Obstetrics, Gynecology, and Perinatology, Russian Agency for Medical Technologies, Moscow

Email: irgly@rambler.ru
Academician V. I. Kulakov Research Center of Obstetrics, Gynecology, and Perinatology, Russian Agency for Medical Technologies, Moscow

Ye Lyashko

Academician V. I. Kulakov Research Center of Obstetrics, Gynecology, and Perinatology, Russian Agency for Medical Technologies, Moscow

Email: irgly@rambler.ru
Academician V. I. Kulakov Research Center of Obstetrics, Gynecology, and Perinatology, Russian Agency for Medical Technologies, Moscow

L Murashko

Academician V. I. Kulakov Research Center of Obstetrics, Gynecology, and Perinatology, Russian Agency for Medical Technologies, Moscow

Email: irgly@rambler.ru
Academician V. I. Kulakov Research Center of Obstetrics, Gynecology, and Perinatology, Russian Agency for Medical Technologies, Moscow

S Khodova

Academician V. I. Kulakov Research Center of Obstetrics, Gynecology, and Perinatology, Russian Agency for Medical Technologies, Moscow

Email: irgly@rambler.ru
Academician V. I. Kulakov Research Center of Obstetrics, Gynecology, and Perinatology, Russian Agency for Medical Technologies, Moscow

Bibliografia

  1. Безнощенко Г. Б., Сафонов А. Д., Ярков А. Н. Желтухи у беременных. - М., 2004.
  2. Ветров В. В. Эфферентная терапия и аутодонорство в акушерстве. - СПб., 2008.
  3. Воинов В. А. Эфферентная терапия. Мембранный плазмаферез: Рекомендации для врачей. - М., 2004.
  4. Иванянов А. И. Беременность и заболевания печени: Метод. пособие. - М., 2005. - С. 45-49.
  5. Кан В. К. // Рус. мед. журн. - 2000. - № 12. - С. 32-35.
  6. Кузьмина В. Н. // Вестн. рос. ассоц. акуш.-гин. - 2001. - № 1. - С. 25-28.
  7. Линева О. И., Осадченко Е. Ю., Нестеренко С. А. и др. // Акуш. и гин. - 2000. - № 6. - С. 15-17.
  8. Макацария А. Д. и др. Синдром диссеминированного внутрисосудистого свертывания крови в акушерской практике. - М., 2002.
  9. Glants A., Marschall H. U., Matsson L. A. // J. Hepatol. - 2004. - Vol. 40. - P. 467-474.
  10. Glantz A., Marschall H. U., Lammert F., Matsson L. A. // J. Hepatol. - 2005. - Vol. 42. - P. 1399-1405.
  11. Kenyon A. P., Girling J. C. // Progr. Obstetr. Gynaecol. - 2005. - Vol. 16. - P. 37-56.
  12. Lammert F., Marschall H. U., Glantz A., Matern S. // J. Hepatol. - 2000. - Vol. 33. - P. 1012-1021.
  13. Li M. K., Crawford J. M. // J. Liver Dis. - 2004. - Vol. 24, N 1. - P. 21-42.
  14. Madore F. // Crit. Care Clin. - 2002. - Vol. 18. - P. 375-392.
  15. Mil S., Houwen R., Klomp L. // J. Med. Genet. - 2005. - Vol. 42. - P. 449-463.
  16. Ropponen A. et al. // J. Hepatol. - 2006. - Vol. 43. - P. 723-728.
  17. Warren J. E., Blaylock R. C., Silver R. M. // Obstetr. and Gynecol. - 2005. - Vol. 192. - P. 2088-2089.

Arquivos suplementares

Arquivos suplementares
Ação
1. JATS XML
Baixar

Este site utiliza cookies

Ao continuar usando nosso site, você concorda com o procedimento de cookies que mantêm o site funcionando normalmente.

Informação sobre cookies